Sign in
CompletedNo phase

Emulation of the RECORD3 Trial Using Healthcare Claims Data

Key facts

Who runs it
Brigham and Women's Hospital
Where
Boston, United StatesSee the site
Trial code
Status
Completed
People taking part
149,248 people enrolled
Started
13 Oct 2024
Ended
15 Jun 2026
Type of study
Observational, 2 groups
Treatments tested
  • Rivaroxaban
  • Enoxaparin
Record updated
10 July 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • At least 18 years of age
  • Scheduled to undergo elective total knee replacement

Who cannot take part

  • Drug or alcohol abuse
  • Concomitant use of protease inhibitors for the treatment of HIV
  • Had a requirement for anticoagulant therapy that could not be stopped
  • Concurrent use of both drugs
  • Had active bleeding or high risk of bleeding
  • Substantial liver disease
  • Severe renal impairment (creatinine clearance <30 ml per minute)
  • Pregnancy or breastfeeding
  • Had contraindications for prophylaxis with enoxaparin
  • Had planned intermittent pneumatic compression

Where in United States

  • Brigham and Women's HospitalBoston, United States

About the trial

What the trial wants to find out

Investigators are building an empirical evidence base for real-world data through large-scale replication of randomized controlled trials. The investigators' goal is to understand for what types of clinical questions real-world data analyses can be conducted with confidence and how to implement such studies.

The 2 groups in the trial

  • Enoxaparin

    Reference group

  • Rivaroxaban

    Exposure group

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
10 July 2026